Javascript must be enabled to continue!
The Effect of Ethynil Estradiol and Desogestrel on Proliferation and Apoptosis Hydatidiform Mole Trophoblast Cell
View through CrossRef
Background: To explore the effect of ethynil estradiol and desogestrel on proliferation and apoptosis hydatidiform mole trophoblast cell.
Methods: From April 2008 until March 2009, we collected 15 samples of hydatidiform mole tissue. Trophoblast cells was isolated and culture at RPMI 20% FBS medium. Only 7 samples (46%) shown good growth. Cell was identified using cytology and β HCG test. Trophoblast cells good quality than devided into three groups observation. First group get ethynil estradiol 10 nmol/mL, second group get desogestrel 100 nmol/mL, Third group get DMSO 1%. Cells incubated and observe at 24, 48, 72, 96 hours. Cell cycle, apoptosis and β HCG was evaluated at each time observation. Cell cycle evaluation using BD cycle test plus DNA reagent, apoptosis evaluation using FITC-Annexin V. Analyze using FACSCalibur flowcytometer. β HCG evaluation using Abbott AxSym total β-HCG reagent pack.
Results: The group of cell that get ethynil estradiol in concentration 10 nmol/mL had cell proliferation index, amount cells and β HCG level higher than control after 72 hours observation. The group of cell that get desogestrel in concentration 100 nmol/mL have cell proliferation index, amount cells and β HCG level lower than control after 48 hours observation. There are no differences of apoptosis between the two group and control.
Conclusion: Ethynil estradiol will increase proliferation of hydatidiform mole trophoblast cell, while desogestrel will decrease proliferation of hydatidiform mole trophoblast cell. There are no effect of ethynil estradiol and desogestrel on apoptosis of hydatidiform mole trophoblast cell.
Title: The Effect of Ethynil Estradiol and Desogestrel on Proliferation and Apoptosis Hydatidiform Mole Trophoblast Cell
Description:
Background: To explore the effect of ethynil estradiol and desogestrel on proliferation and apoptosis hydatidiform mole trophoblast cell.
Methods: From April 2008 until March 2009, we collected 15 samples of hydatidiform mole tissue.
Trophoblast cells was isolated and culture at RPMI 20% FBS medium.
Only 7 samples (46%) shown good growth.
Cell was identified using cytology and β HCG test.
Trophoblast cells good quality than devided into three groups observation.
First group get ethynil estradiol 10 nmol/mL, second group get desogestrel 100 nmol/mL, Third group get DMSO 1%.
Cells incubated and observe at 24, 48, 72, 96 hours.
Cell cycle, apoptosis and β HCG was evaluated at each time observation.
Cell cycle evaluation using BD cycle test plus DNA reagent, apoptosis evaluation using FITC-Annexin V.
Analyze using FACSCalibur flowcytometer.
β HCG evaluation using Abbott AxSym total β-HCG reagent pack.
Results: The group of cell that get ethynil estradiol in concentration 10 nmol/mL had cell proliferation index, amount cells and β HCG level higher than control after 72 hours observation.
The group of cell that get desogestrel in concentration 100 nmol/mL have cell proliferation index, amount cells and β HCG level lower than control after 48 hours observation.
There are no differences of apoptosis between the two group and control.
Conclusion: Ethynil estradiol will increase proliferation of hydatidiform mole trophoblast cell, while desogestrel will decrease proliferation of hydatidiform mole trophoblast cell.
There are no effect of ethynil estradiol and desogestrel on apoptosis of hydatidiform mole trophoblast cell.
Related Results
The Effect of Ethynil Estradiol and Desogestrel on Proliferation and Apoptosis Hydatidiform Mole Trophoblast Cell
The Effect of Ethynil Estradiol and Desogestrel on Proliferation and Apoptosis Hydatidiform Mole Trophoblast Cell
A B S T R A C TIntroduction To explore the effect of ethynil estradiol and desogestrel onproliferation and apoptosis hydatidiform mole trophoblast cell. Methods: From April2008 unt...
Three Consecutive Complete Hydatidiform Moles: A Rare and Challenging Pattern of Gestational Trophoblastic Disease
Three Consecutive Complete Hydatidiform Moles: A Rare and Challenging Pattern of Gestational Trophoblastic Disease
Introduction Recurrent hydatidiform mole is an uncommon gestational trophoblastic disease but is clinically important. Although a single molar pregnancy is generally well understoo...
HER2 Amplification in Hydatidiform mole patients
HER2 Amplification in Hydatidiform mole patients
Hydatidiform mole is an abnormal pregnancy in which the placenta contains grape cell like vesicles (small sacs) , that are usually visible with the naked eye .Patients and methods ...
Degradation of extracellular matrix by mouse trophoblast outgrowths: a model for implantation
Degradation of extracellular matrix by mouse trophoblast outgrowths: a model for implantation
During implantation the embryo attaches to the endometrial surface and trophoblast traverses the uterine epithelium, anchoring in the uterine connective tissue. To determine whethe...
The Association of Thyroid Hormones With β-HCG in Patients With Hydatidiform Mole
The Association of Thyroid Hormones With β-HCG in Patients With Hydatidiform Mole
Background: A hydatidiform mole or molar pregnancy is the most prevalent gestational trophoblastic disease (GTD). About 55%-60% of women with trophoblastic diseases have overt hype...
L26/O-271 The clinical impact of the progesterone-to-estradiol ratio on blastocyst development is confined to low-estradiol IVF cycles
L26/O-271 The clinical impact of the progesterone-to-estradiol ratio on blastocyst development is confined to low-estradiol IVF cycles
Abstract
Study question
Does the progesterone-to-estradiol ratio predict good-quality blastocyst formation, and is its im...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy
Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy
Purpose:
In trans people undergoing feminizing hormone therapy, optimal estradiol concentrations are unclear, and anecdotally, some individuals desire supraphys...

